Community Academic Profiles–

Jonathan S. Berek

Back to Profile

Publication Details

  • Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience.

    Markman M, Brady M, Hutson A, Berek JS. Int J Gynecol Cancer. 2009; 19 (2): 223-9

    To assess the association between patient-disease characteristics and overall survival (OS) after second-line intraperitoneal (IP) treatment of ovarian cancer.

    PubMedID: 19395997

Stanford Medicine Resources:

Footer Links: